Palonosetron
- Level
- Commodity
- Parent
- 51171800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171822This classification denotes a 5-ht3 receptor antagonist and antiemetic agent with the molecular formula C19H24N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5D06587D6R, chemically known as 2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1h-benz(de)isoquinolin-1-one but generally known as palonosetron, which bears US NIH Compound Identifier 148211. European Medicines Agency schedules Palonosetron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09593MIG. The term PALONOSETRON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, No. 3, 1996, List 36). World Health Organization schedules palonosetron in its Anatomical Therapeutic Chemical (ATC) Classification. PALONOSETRON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule palonosetron under HS 29337900 and SITC 51561. As of Q4 2014, PALONOSETRON remains the US FDA Preferred Term for this commodity. Palonosetron bears US NLM identifiers UMLS ID C0220578 and NCI Concept Code C61874. SMILES: O=C1N(C2C3CCN(C2)CC3)CC2C3C1CCCC3CCC2.
Same parent
Under 51171800 · 49Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.